CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities:
Net loss	$ (205,031)	$ (22,328)	$ (218,772)	$ (433,532)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	15,476	12,298	30,096	25,602
Stock-based compensation	265,785	145,820	439,416	246,727
Deferred income taxes	3,291	(427)	4,813	(2,041)
Net loss on exchange derivative and capped call transactions	0	0	0	424,482
Amortization of debt discount and issuance cost	117	16,975	235	26,816
Net loss on strategic investments	7,563	22,135	19,076	53,557
Net foreign currency gain	(2,203)	(5,258)	(5,828)	(11,656)
Gain on a non-cash sale of a controlling interest of a subsidiary	(2,066)	0	(45,158)	0
Other	(5)	297	(5)	(318)
Changes in operating assets and liabilities:
Accounts receivable, net	(107,805)	(54,992)	(46,491)	(68,203)
Prepaid expenses and other assets	(2,690)	(3,897)	(25,367)	(25,082)
Accounts payable	18,587	10,284	49,734	20,507
Accrued expenses and other liabilities	58,260	21,119	(50,183)	(63,287)
Deferred revenue	101,246	64,429	91,401	77,884
Net cash provided by operating activities	150,525	206,455	242,967	271,456
Cash flows from Investing activities:
Business combinations, net of cash acquired	0	(2,701)	(600)	(3,839)
Purchases of property and equipment	(4,040)	(12,581)	(20,536)	(19,462)
Purchases of strategic investments	(1,100)	(42,000)	(9,450)	(95,000)
Purchases of marketable securities	0	0	(10,000)	(21,003)
Proceeds from maturities of marketable securities	18,750	7,600	47,700	61,487
Proceeds from sales of marketable securities and strategic investments	363	0	621	186,262
Net cash provided by (used in) investing activities	13,973	(49,682)	7,735	108,445
Cash flows from financing activities:
Proceeds from term loan facility	0	350,000	0	1,000,000
Repayment of exchangeable senior notes	0	(1,234,376)	0	(1,548,686)
Proceeds from settlement of capped call transactions	0	104,519	0	135,497
Proceeds from other financing arrangements	0	4	1,396	5
Net cash provided by (used in) financing activities	0	(779,853)	1,396	(413,184)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash	3,522	(246)	(1,417)	(2,355)
Net increase (decrease) in cash, cash equivalents, and restricted cash	168,020	(623,326)	250,681	(35,638)
Cash, cash equivalents, and restricted cash at beginning of period	1,469,949	1,519,213	1,386,686	931,023
Net decrease in cash and cash equivalents included in assets held for sale	0	4,182	602	4,684
Cash, cash equivalents, and restricted cash at end of period	1,637,969	900,069	1,637,969	900,069
Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:
Cash and cash equivalents			1,385,265
Restricted cash included in other non-current assets	1,354	675	1,354	675
Total cash, cash equivalents, and restricted cash	1,637,969	900,069	1,637,969	900,069
Supplemental disclosures of cash flow information:
Income taxes paid, net of refunds	63,742	42,611	92,962	53,941
Interest paid	6,813	3,603	12,388	4,802
Non-cash investing and financing activities:
Purchase of property and equipment included in accrued expenses and other current liabilities	$ 1,385	$ 5,062	$ 1,385	$ 5,062